Wealth Enhancement Advisory Services, LLC Halozyme Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 20,820 shares of HALO stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,820
Previous 12,479
66.84%
Holding current value
$1.17 Million
Previous $596,000
122.82%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
595Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$988 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$719 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$339 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$218 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$206 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.81B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...